AI assistant
Ambu — Share Issue/Capital Change 2016
Nov 30, 2016
3353_iss_2016-11-30_b1b02c14-5099-4001-97da-d0062524336b.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Ambu A/S – Disclosure requirement concerning share capital
Under section 6 of the Danish Executive Order on disclosure requirements for issuers, Ambu A/S is to announce the total share capital of Ambu A/S by the end of a month in which any change of the share capital was effected.
The table below shows the total share capital of Ambu A/S as at 30 November 2016, see also company announcement no. 4-2016/17.
| Number of shares | Nominal value | |
|---|---|---|
| (nominal value DKK 2.5) | (DKK) | |
| A shares | 6,864,000 | 17,160,000 |
| B shares | 41,523,120 | 103,807,800 |
| Total | 48,387,120 | 120,967,800 |
Contact
Lars Marcher, President & CEO, tel. +45 5136 2490, email: [email protected]
Ambu A/S Baltorpbakken 13 DK-2750 Ballerup CVR no.: 63 64 49 19 Tel. +45 7225 2000 www.ambu.com
About Ambu
Since 1937, breakthrough ideas have fuelled our work on bringing efficient healthcare solutions to life. This is what we create within our fields of excellence – Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. Millions of patients and healthcare professionals worldwide depend on the functionality and performance of our products. We are dedicated to improve patient safety and determined to advance single-use devices. The manifestations of our efforts range from early inventions like the Ambu Bag™ resuscitator and the legendary BlueSensor™ electrodes to our newest landmark solutions like the aScope™ endoscope – the world's first single-use flexible video scope. Our commitment to bringing new ideas and superior service to our customers has made Ambu one of the most recognized medical companies in the world. Headquartered near Copenhagen in Denmark, Ambu employs approximately 2,350 people in Europe, North America and the Asia Pacific. For more information, please visit www.ambu.com.